Recall

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter

Headline as published by U.S. Food and Drug Administration (MedWatch).

Read at U.S. Food and Drug Administration (MedWatch)

FOR IMMEDIATE RELEASE – September 3, 2026– Bethlehem, PA, B. Braun Medical Inc (B. Braun) is voluntarily recalling three (3) lots of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container, to the hospital/healthcare facility/user level due to presence of particulate matter identified

From U.S. Food and Drug Administration (MedWatch)’s feed

Topics

Tags are matched against PI Data Hub’s own index of firms, bar associations, conferences and the JPML’s active MDL list. The quoted words are the exact text that produced each tag. Nothing on this page is written by AI. Sources and method